Insider Buy/Sell Details for the Biotechnology Industry — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1261)
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
9,029
Price
$3.05
Total Value
$27.54K
Shares Held After
105,989
% of Holdings
7.9%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
2,842
Price
$38.96
Total Value
$110.72K
Shares Held After
180,597
% of Holdings
1.5%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
14,982
Price
$38.19
Total Value
$572.16K
Shares Held After
183,439
% of Holdings
7.6%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
100
Price
$26.39
Total Value
$2.64K
Shares Held After
33,054
% of Holdings
0.3%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,358
Price
$25.55
Total Value
$34.70K
Shares Held After
32,954
% of Holdings
4.1%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
4,212
Price
$24.90
Total Value
$104.88K
Shares Held After
31,596
% of Holdings
13.3%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
580
Price
$23.61
Total Value
$13.69K
Shares Held After
27,384
% of Holdings
2.1%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
1,500
Price
$38.01
Total Value
$57.02K
Shares Held After
116,731
% of Holdings
1.3%
Immunovant, Inc. (IMVT)
Girao Tiago — Chief Financial Officer
Shares
10,000
Price
$38.46
Total Value
$384.60K
Shares Held After
247,596
% of Holdings
3.9%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
6,723
Price
$38.94
Total Value
$261.79K
Shares Held After
211,685
% of Holdings
3.1%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
33,277
Price
$38.18
Total Value
$1.27M
Shares Held After
218,408
% of Holdings
13.2%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
2,966
Price
$38.95
Total Value
$115.53K
Shares Held After
224,393
% of Holdings
1.3%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
14,748
Price
$38.18
Total Value
$563.08K
Shares Held After
227,359
% of Holdings
6.1%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
50,000
Price
$80.59
Total Value
$4.03M
Shares Held After
245,571
% of Holdings
16.9%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
191
Price
$56.27
Total Value
$10.75K
Shares Held After
134,215
% of Holdings
0.1%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
602
Price
$55.30
Total Value
$33.29K
Shares Held After
134,406
% of Holdings
0.4%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
207
Price
$54.22
Total Value
$11.22K
Shares Held After
135,008
% of Holdings
0.2%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
332
Price
$55.99
Total Value
$18.59K
Shares Held After
134,215
% of Holdings
0.2%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
356
Price
$55.23
Total Value
$19.66K
Shares Held After
134,547
% of Holdings
0.3%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
312
Price
$54.34
Total Value
$16.96K
Shares Held After
134,903
% of Holdings
0.2%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
6,417
Price
$56.12
Total Value
$360.13K
Shares Held After
452,466
% of Holdings
1.4%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
9,137
Price
$55.27
Total Value
$504.96K
Shares Held After
458,883
% of Holdings
2.0%
Vaxcyte, Inc. (PCVX)
PICKERING GRANT — Director
Shares
6,683
Price
$54.27
Total Value
$362.72K
Shares Held After
468,020
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
BVF PARTNERS L P/IL — Director
Shares
51,858
Price
$106.50
Total Value
$5.52M
Shares Held After
78,787
% of Holdings
39.7%
Kymera Therapeutics, Inc. (KYMR)
BVF PARTNERS L P/IL — Director
Shares
113,289
Price
$106.50
Total Value
$12.07M
Shares Held After
240,123
% of Holdings
32.1%
Kymera Therapeutics, Inc. (KYMR)
BVF PARTNERS L P/IL — Director
Shares
627,597
Price
$106.50
Total Value
$66.84M
Shares Held After
1,592,261
% of Holdings
28.3%
Kymera Therapeutics, Inc. (KYMR)
BVF PARTNERS L P/IL — Director
Shares
837,914
Price
$106.50
Total Value
$89.24M
Shares Held After
1,960,881
% of Holdings
29.9%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
10,000
Price
$87.14
Total Value
$871.40K
Shares Held After
97,994
% of Holdings
9.3%
Spyre Therapeutics, Inc. (SYRE)
Burrows Scott L — Chief Financial Officer
Shares
5,000
Price
$87.12
Total Value
$435.60K
Shares Held After
107,994
% of Holdings
4.4%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
2,127
Price
$3.00
Total Value
$6.38K
Shares Held After
115,018
% of Holdings
1.8%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
21,072
Price
$78.49
Total Value
$1.65M
Shares Held After
245,571
% of Holdings
7.9%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
10,602
Price
$79.18
Total Value
$839.49K
Shares Held After
21,759
% of Holdings
32.8%
Krystal Biotech, Inc. (KRYS)
Thomas John Charles — EVP, General Counsel
Shares
1,000
Price
$347.27
Total Value
$347.27K
Shares Held After
0
% of Holdings
100.0%
uniQure N.V. (QURE)
Kapusta Matthew C — Director
Shares
28,716
Price
$50.02
Total Value
$1.44M
Shares Held After
519,227
% of Holdings
5.2%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
100
Price
$87.00
Total Value
$8.70K
Shares Held After
60,137
% of Holdings
0.2%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
11,337
Price
$86.51
Total Value
$980.76K
Shares Held After
60,137
% of Holdings
15.9%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
8,522
Price
$85.26
Total Value
$726.59K
Shares Held After
71,474
% of Holdings
10.7%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
419
Price
$86.39
Total Value
$36.20K
Shares Held After
60,137
% of Holdings
0.7%
PTC THERAPEUTICS, INC. (PTCT)
Almstead Neil Gregory — CHIEF TECHNICAL OPS OFFICER
Shares
582
Price
$85.24
Total Value
$49.61K
Shares Held After
60,556
% of Holdings
1.0%
Definium Therapeutics, Inc. (DFTX)
Barrow Robert — Director
Shares
29,208
Price
$45.03
Total Value
$1.32M
Shares Held After
1,098,246
% of Holdings
2.6%
Definium Therapeutics, Inc. (DFTX)
Roberts Brandi — Chief Financial Officer
Shares
3,013
Price
$45.03
Total Value
$135.68K
Shares Held After
209,487
% of Holdings
1.4%
Definium Therapeutics, Inc. (DFTX)
Sullivan Mark — Chief Legal Officer
Shares
13,008
Price
$45.03
Total Value
$585.75K
Shares Held After
320,571
% of Holdings
3.9%
Greenland Mines Ltd (GRML)
El-Dada Riad Hussein — Director
Shares
175,000
Price
$0.23
Total Value
$40.55K
Shares Held After
175,000
% of Holdings
50.0%
Definium Therapeutics, Inc. (DFTX)
Wiley Matthew T. — Chief Commercial Officer
Shares
2,867
Price
$45.03
Total Value
$129.10K
Shares Held After
174,633
% of Holdings
1.6%
Definium Therapeutics, Inc. (DFTX)
Karlin Daniel — Chief Medical Officer
Shares
10,035
Price
$45.03
Total Value
$451.88K
Shares Held After
503,282
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$554.84
Total Value
$133.16K
Shares Held After
40,513
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$553.97
Total Value
$443.17K
Shares Held After
40,753
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,778
Price
$552.68
Total Value
$982.67K
Shares Held After
41,553
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,814
Price
$551.61
Total Value
$1.00M
Shares Held After
43,331
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,617
Price
$550.86
Total Value
$890.75K
Shares Held After
45,145
% of Holdings
3.5%
Showing 1–50 of 1261 transactions (page 1 of 26)